跳至主要内容
临床试验/NL-OMON26761
NL-OMON26761
招募中
不适用

Feasibility of a 13-week resistance exercise and protein supplementation intervention in sarcopenic geriatric rehabilitation inpatients admitted after a hip fracture: EMPOWER-GR

Vrije Universiteit Amsterdam0 个研究点目标入组 80 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
Vrije Universiteit Amsterdam
入组人数
80
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

入排标准

入选标准

  • 1\) Admitted to a geriatric rehabilitation centre for a hip fracture
  • 2\) Aged 65 years or older
  • 3\) Diagnosed with stage 1 or 2 sarcopenia (sarcopenia probable or confirmed) according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2\) definition
  • 4\) Written informed consent

排除标准

  • 1\) Palliative care or other adverse prognosis precluding post\-intervention follow\-up
  • 2\) Specific medical history such as:
  • Patients with ongoing cancer treatment or radiotherapy/ chemotherapy in the last 6 months.
  • Any gastrointestinal disease that interferes with bowel function and nutritional intake (e.g. constipation or diarrhoea secondary to neuropathy, diarrhoea due to chronic inflammatory bowel disease, gastroparesis, (partial) gastrectomy or any other procedure for stomach volume reduction, including gastric banding)
  • Other relevant medical history or medication that could prevent participation in the intervention or affect the study outcome as judged by the investigator (e.g. severe dementia, hypercalcaemia)
  • 3\) Patients in isolation/quarantaine
  • 4\) BMI \>40 kg/m2 (morbid obesity)
  • 5\) Renal impairment (estimated Glomerular Filtration Rate \<30 mL/min/1\.73m2\)
  • 6\) Dietary characteristics: known allergy to cow’s milk and milk products or the ingredients of the study products, known allergy to soy, known galactosaemia, known severe lactose intolerance, patients requiring a fibre\-free diet
  • 7\) Current alcohol or drug abuse in opinion of the investigator

结局指标

主要结局

未指定

相似试验